KATHERINE BURLINGAME: Open Payments
NPI 1083029482 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,615 in 69 payments from 17 companies in 2025. Trend: 2023 $935 · 2024 $2,340 · 2025 $2,615
Food & beverage: $1,615Consulting: $900Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $982 |
| Janssen Biotech, Inc. | 8 | $354 |
| UCB, Inc. | 17 | $264 |
| Lilly USA, LLC | 8 | $215 |
| ABBVIE INC. | 11 | $207 |
| Regeneron Healthcare Solutions, Inc. | 3 | $162 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Amgen Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, TALTZ, EBGLYSS, COSENTYX, OTEZLA.
Industry payments across NY — which companies pay providers there.
